PETS
PETMED EXPRESS INC
$1.85
+0.54%
$39.5M
No data for this timeframe.
Vol
Market Cap$39.5M
Cap SizeNano Cap
Inst. Holders25 funds
Inst. Value$10.6M
Inst. Activity2 buys / 5 sells
Insider Activity1B / 0S
Insider Net $$43.7K
Reddit Sentiment60° Warm
SEC Reports3
Press Releases1
Exchange Nasdaq·Sector Retail-Drug Stores and Proprietary Stores·Inc. FL·CIK 0001040130·Prev Close $1.84
Recent Activity
Jun 8, 2026
Insider
NINA CAPITAL HOLDINGS INC. bought 25,000 shares
10%+ Owner @ $1.75 ($43.7K)
Jun 2, 2026
SEC
PetMed Express reported Q4 FY2026 net sales of $42.8M, down 15.6% YoY, and a net loss of $4.1M ($0.19/share), narrowing
8-K — Impact 7/10
Jun 2, 2026
SEC
PetMed Express reported Q4 FY2026 net sales of $42.8M (-15.6% YoY) and a net loss of $4.1M ($0.19/share), narrowing from
PRESS-RELEASE — Impact 6/10
Jun 2, 2026
earnings
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
<p>DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and pare
May 29, 2026
SEC
PetMed Express announced it will report Q4 and fiscal year 2026 results on June 2, 2026, after market close. The press r
PRESS-RELEASE — Impact 2/10
Inst.
HOTCHKIS & WILEY CAPITAL — TRIM
514,543 shares ($1.2M)
Inst.
DIMENSIONAL FUND ADVISORS LP — TRIM
207,769 shares ($473.7K)
Apr 22, 2026
Press
PetMed Express (PETS) announced a strategic partnership with Rural King to launch a nationwide pet pharmacy service, lev
Impact 7/10
Price Targets
Historical data — last covering-analyst action Apr 2025. No current recommendation available.
$2.15 (Apr 2025)
Current $1.85
Low $2.15
Median $2.15
High $2.15
1 analysts
$2.15
$2.15
Analyst Ratings
0Strong Buy
0Buy
2Hold
2Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 17, 2025 | Morgan Stanley | MAINTAIN | Underweight → Underweight |
| Aug 7, 2024 | Lake Street | DOWNGRADE | Buy → Hold |
| Jun 12, 2024 | Lake Street | MAINTAIN | Buy → Buy |
| Jun 12, 2024 | Morgan Stanley | MAINTAIN | Underweight → Underweight |
| Nov 16, 2023 | Morgan Stanley | MAINTAIN | Underweight → Underweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.12 | $0.12 — $0.12 | 107% YoY | 1 |
| Next Q | $-0.06 ▼ -160.0% | $-0.06 — $-0.06 | 85% YoY | 1 |
| Current FY | $0.07 ▲ +600.0% | $0.07 — $0.07 | 103% YoY | 1 |
| Next FY | $0.09 ▲ +350.0% | $0.09 — $0.09 | 29% YoY | 1 |
Latest Reports
BEARISH
8-K
7/10
PetMed Express reported Q4 FY2026 net sales of $42.8M, down 15.6% YoY, and a net loss of $4.1M ($0.19/share), narrowing
Jun 2, 2026
BEARISH
PRESS-RELEASE
6/10
PetMed Express reported Q4 FY2026 net sales of $42.8M (-15.6% YoY) and a net loss of $4.1M ($0.19/share), narrowing from
Jun 2, 2026
BULLISH
Press
7/10
PetMed Express (PETS) announced a strategic partnership with Rural King to launch a nationwide pet pharmacy service, lev
Apr 22, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | DOUBLED |
| RENAISSANCE TECHNOLOGIES LLC | $2.7M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.9M | — |
| FEDERATED HERMES, INC. | $1.5M | ADD |
| BlackRock, Inc. | $1.3M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | NINA CAPITAL | BUY | $43.7K |
Reddit Sentiment
60°
Warm
Bearish
Neutral
Bullish
25 institutional holders with $10.6M total value (4,765,101 shares) as of 2026-Q1. Top holders: ROYAL, RENAISSANCE, VANGUARD. Net selling activity: 5 institutions trimmed/exited vs 2 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 147 | $0.00 | 0.0% | DOUBLED +102.5% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 1,186,369 | $2.7M | 25.5% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 831,431 | $1.9M | 17.9% | — |
| 4 | FEDERATED HERMES, INC. | 666,805 | $1.5M | 14.4% | ADD +30.1% |
| 5 | BlackRock, Inc. | 551,677 | $1.3M | 11.9% | — |
| 6 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 514,543 | $1.2M | 11.1% | TRIM -34.7% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 207,769 | $473.7K | 4.5% | TRIM -48.8% |
| 8 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 126,774 | $289.0K | 2.7% | TRIM -27.7% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 109,712 | $250.1K | 2.4% | — |
| 10 | STATE STREET CORP | 105,173 | $239.8K | 2.3% | — |
| 11 | CITADEL ADVISORS LLC | 87,894 | $200.4K | 1.9% | ADD +40.0% |
| 12 | AMERIPRISE FINANCIAL INC | 73,400 | $167.4K | 1.6% | TRIM -29.4% |
| 13 | GROUP ONE TRADING LLC | 71,117 | $162.1K | 1.5% | DOUBLED +2197.1% |
| 14 | BLAIR WILLIAM & CO/IL | 30,400 | $69.3K | 0.7% | ADD +95.2% |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 27,800 | $63.4K | 0.6% | — |
| 16 | SEI INVESTMENTS CO | 23,000 | $52.4K | 0.5% | ADD +42.0% |
| 17 | MORGAN STANLEY | 11,380 | $25.9K | 0.2% | DOUBLED +214.6% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 10,066 | $22.9K | 0.2% | NEAR_EXIT -90.8% |
| 19 | Vanguard Global Advisers, LLC | 8,120 | $18.5K | 0.2% | — |
| 20 | Allworth Financial LP | 494 | $1.1K | 0.0% | TRIM -30.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | TRIM | 788,103 | 514,543 | -34.7% | $1.2M | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | TRIM | 405,896 | 207,769 | -48.8% | $473.7K | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 175,233 | 126,774 | -27.7% | $289.0K | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | TRIM | 104,000 | 73,400 | -29.4% | $167.4K | 2026-Q1 |
| GROUP ONE TRADING LLC | DOUBLED | 3,096 | 71,117 | +2197.1% | $162.1K | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 16,200 | 23,000 | +42.0% | $52.4K | 2026-Q1 |
| FMR LLC | TRIM | 400 | 200 | -50.0% | $456.00 | 2026-Q1 |
| FEDERATED HERMES, INC. | ADD | 482,386 | 627,743 | +30.1% | $2.0M | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 4,224 | 13,289 | +214.6% | $42.5K | 2025-Q4 |
| GROUP ONE TRADING LLC | NEAR_EXIT | 13,847 | 3,096 | -77.6% | $9.9K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 355 | 476 | +34.1% | $1.5K | 2025-Q4 |
| FMR LLC | TRIM | 550 | 400 | -27.3% | $1.3K | 2025-Q4 |
| CITADEL ADVISORS LLC | ADD | 129,895 | 181,879 | +40.0% | $456.5K | 2025-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 246,430 | 175,233 | -28.9% | $439.8K | 2025-Q3 |
| AMERIPRISE FINANCIAL INC | TRIM | 142,973 | 104,173 | -27.1% | $261.5K | 2025-Q3 |
| Invesco Ltd. | TRIM | 73,083 | 36,078 | -50.6% | $90.6K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 28,104 | 4,224 | -85.0% | $10.6K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 77,185 | 745 | -99.0% | $1.9K | 2025-Q3 |
| FMR LLC | NEAR_EXIT | 2,830 | 550 | -80.6% | $1.4K | 2025-Q3 |
| Allworth Financial LP | TRIM | 712 | 494 | -30.6% | $1.2K | 2025-Q3 |
| Russell Investments Group, Ltd. | TRIM | 447 | 124 | -72.3% | $311.00 | 2025-Q3 |
| ROYAL BANK OF CANADA | DOUBLED | 42,329 | 85,716 | +102.5% | $284.0K | 2025-Q2 |
| Invesco Ltd. | TRIM | 114,867 | 73,083 | -36.4% | $242.6K | 2025-Q2 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | ADD | 11,541 | 15,943 | +38.1% | $52.9K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 12,587 | 456 | -96.4% | $1.5K | 2025-Q2 |
1 unique insiders with 1 transactions. Net insider value: $43.7K ($43.7K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | NINA CAPITAL HOLDINGS INC. | 10%+ Owner | BUY | 25,000 | $1.75 | $43.7K |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
BEARISH
8-K
7/10
PetMed Express reported Q4 FY2026 net sales of $42.8M, down 15.6% YoY, and a net loss of $4.1M ($0.1
Jun 2, 2026
BEARISH
PRESS-RELEASE
6/10
PetMed Express reported Q4 FY2026 net sales of $42.8M (-15.6% YoY) and a net loss of $4.1M ($0.19/sh
Jun 2, 2026
NEUTRAL
PRESS-RELEASE
2/10
PetMed Express announced it will report Q4 and fiscal year 2026 results on June 2, 2026, after marke
May 29, 2026
Historical analyst distribution (last covering-analyst action Apr 2025): 0% buy across 6 analysts — 0 strong buy, 0 buy, 2 hold, 2 sell, 2 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Apr 2025. No current recommendation available.
$2.15 mean target (Apr 2025)
$2.15 Low
$2.15 High
| Metric | Value |
|---|---|
| Current Price | $1.85 |
| Target Low | $2.15 |
| Target Mean | $2.15 |
| Target Median | $2.15 |
| Target High | $2.15 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.12 | $0.12 | $0.12 | 107.3% | — | — | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$-0.06 | $-0.06 | $-0.06 | 85.4% | -160.0% | 0↑ 1↓ | $0.0B | — | 1 |
| Current FY 2027-03-31 |
$0.07 | $0.07 | $0.07 | 102.6% | +600.0% | 1↑ 0↓ | $0.2B | 0.7% | 1 |
| Next FY 2028-03-31 |
$0.09 | $0.09 | $0.09 | 28.6% | +350.0% | 1↑ 0↓ | $0.2B | 2.3% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.120 | |
| 7d ago | $0.000 | +0.120 |
| 30d ago | $0.000 | +0.120 |
| 60d ago | $0.000 | +0.120 |
| 90d ago | $0.000 | +0.120 |
9 analyst firms have rated this stock: 8 upgrades, 7 downgrades, 5 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 17, 2025 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Aug 7, 2024 | Lake Street | DOWNGRADE | Buy | Hold |
| Jun 12, 2024 | Lake Street | MAINTAIN | Buy | Buy |
| Jun 12, 2024 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Nov 16, 2023 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Oct 31, 2023 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Oct 19, 2023 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Jul 27, 2023 | Morgan Stanley | REITERATE | Underweight | Underweight |
| May 25, 2023 | Lake Street | INITIATE | — | Buy |
| Mar 23, 2023 | Morgan Stanley | MAINTAIN | — | Underweight |
| Nov 8, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Jul 26, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| May 10, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Jan 25, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Jan 20, 2022 | Sidoti & Co. | UPGRADE | Neutral | Buy |
| Nov 18, 2021 | Morgan Stanley | INITIATE | — | Underweight |
| Oct 1, 2021 | Jefferies | INITIATE | — | Hold |
| Jun 3, 2021 | Sidoti & Co. | DOWNGRADE | Buy | Neutral |
| Mar 5, 2021 | Sidoti & Co. | UPGRADE | Neutral | Buy |
| Aug 19, 2020 | Sidoti & Co. | UPGRADE | Neutral | Buy |
| Feb 24, 2020 | Sidoti & Co. | DOWNGRADE | Buy | Neutral |
| Oct 17, 2019 | Craig-Hallum | MAINTAIN | — | Hold |
| Aug 16, 2019 | Craig-Hallum | DOWNGRADE | Buy | Hold |
| Jul 9, 2018 | Craig-Hallum | DOWNGRADE | Hold | Sell |
| Jun 15, 2018 | CL King | INITIATE | — | Neutral |
| Aug 24, 2017 | Sidoti & Co. | UPGRADE | Neutral | Buy |
| Jul 24, 2017 | Northcoast Research | UPGRADE | Neutral | Buy |
| Jul 11, 2017 | Craig-Hallum | DOWNGRADE | Buy | Hold |
| May 9, 2016 | Craig-Hallum | UPGRADE | Sell | Hold |
| Feb 3, 2016 | Credit Suisse | INITIATE | — | Underperform |
| May 1, 2014 | Northcoast Research | DOWNGRADE | Buy | Neutral |
| Mar 8, 2013 | Northcoast Research | UPGRADE | Sell | Buy |
| Apr 2, 2012 | Piper Sandler | UPGRADE | Underweight | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
60°
Warm
Bearish
Neutral
Bullish
1 mentions
1 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Jun 2, 2026
earnings
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
<p>DELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today annou
May 29, 2026
earnings
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
<p>DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today anno
Apr 22, 2026
contract
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
Collaboration expands access to affordable pet medications for rural communities nationwide <pre>Collaboration expands access to affordable pet medica